Biotech companies by one-year price change
How far the share price has moved over the last 52 weeks.
Moderna leads the 24 biotech companies ranked by one-year price change, at +755%, ahead of Kodiak Sciences (+396%) and Twist Bioscience (+340%). Figures as of 18 Nov 2026, 20:14 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- First
- Moderna+755%
- Median
- +40.0%
- Combined market value
- SGD 1.08T
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ModernaMRNA · Health Care | +755% | SGD 103.5B | SGD 255.82 | 4.09% down | 755% up | ||
| 2 | Kodiak SciencesKOD · Health Care | +396% | SGD 8.2B | SGD 125.62 | 0.61% up | 396% up | ||
| 3 | Twist BioscienceTWST · Health Care | +340% | SGD 10.3B | SGD 150.39 | 4.11% up | 340% up | ||
| 4 | ImmunityBioIBRX · Health Care | +193% | SGD 9.2B | SGD 8.61 | 6.67% up | 193% up | ||
| 5 | Revolution MedicinesRVMD · Health Care | +131% | SGD 44.6B | SGD 206.09 | 1.79% down | 131% up | ||
| 6 | Adaptive BiotechnologiesADPT · Health Care | +88.1% | SGD 6B | SGD 36.89 | 0.39% up | 88% up | ||
| 7 | Kymera TherapeuticsKYMR · Health Care | +87.5% | SGD 13.4B | SGD 156.40 | 0.21% down | 87% up | ||
| 8 | CG OncologyCGON · Health Care | +85.3% | SGD 9.2B | SGD 103.31 | 1.47% up | 85% up | ||
| 9 | ExelixisEXEL · Health Care | +62.6% | SGD 21.6B | SGD 88.39 | 0.04% up | 63% up | ||
| 10 | BiogenBIIB · Health Care | +49.3% | SGD 47.7B | SGD 322.36 | 0.34% down | 49% up | ||
| 11 | Krystal BiotechKRYS · Health Care | +46.3% | SGD 12B | SGD 404.97 | 5.17% up | 46% up | ||
| 12 | ImmunovantIMVT · Health Care | +43.4% | SGD 8.9B | SGD 43.03 | 0.45% up | 43% up | ||
| 13 | Halozyme TherapeuticsHALO · Health Care | +36.6% | SGD 14.1B | SGD 124.00 | 0.18% up | 37% up | ||
| 14 | AmgenAMGN · Health Care | +33.7% | SGD 309.5B | SGD 572.18 | 3.12% down | 34% up | ||
| 15 | Gilead SciencesGILD · Health Care | +32.9% | SGD 270.4B | SGD 217.98 | 0.74% down | 33% up | ||
| 16 | Bio-TechneTECH · Health Care | +25.6% | SGD 14.7B | SGD 93.88 | 0.21% up | 26% up | ||
| 17 | VaxcytePCVX · Health Care | +22.2% | SGD 11.9B | SGD 75.47 | 1.50% down | 22% up | ||
| 18 | Neurocrine BiosciencesNBIX · Health Care | +20.2% | SGD 21.3B | SGD 210.17 | 1.79% down | 20% up | ||
| 19 | Scholar Rock HoldingSRRK · Health Care | +13.6% | SGD 7.6B | SGD 61.95 | 6.54% up | 14% up | ||
| 20 | QiagenQGEN · Health Care | +12.0% | SGD 13.2B | SGD 63.98 | 0.29% down | 12% up | ||
| 21 | RepligenRGEN · Health Care | +4.58% | SGD 14.2B | SGD 222.79 | 6.51% up | 5% up | ||
| 22 | argenxARGX · Health Care | +3.60% | SGD 76.6B | SGD 1,218.16 | 0.32% down | 4% up | ||
| 23 | BioNTechBNTX · Health Care | -16.3% | SGD 26.7B | SGD 107.84 | 1.47% down | 16% down | ||
| 24 | CRISPR TherapeuticsCRSP · Health Care | -20.9% | SGD 5.1B | SGD 52.30 | 1.00% up | 21% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2898 SGD).
Questions and answers
Which biotech companies rank first by one-year price change?
Moderna (+755%), Kodiak Sciences (+396%) and Twist Bioscience (+340%) are the top three of the 24 biotech companies ranked by one-year price change as of 18 Nov 2026, 20:14 UTC.
How many biotech companies are in this ranking?
24 are ranked by one-year price change.
What are these biotech companies worth together?
The 24 biotech companies ranked by one-year price change have a combined market value of SGD 1.08T as of 18 Nov 2026, 20:14 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Biotech companies by one-year price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.